Yes, I did mention that before that I’m counting on NGIO getting listed. And that should not be a problem going forward with the new China deal. I would think the SEC now will see that we have funding behind us and might be more likely to approve our S1 application.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.